July 29-30, 2013 | San Francisco
MBHB partner Kevin Noonan, Ph.D. is a featured presenter and MBHB partner Paul Tully, Ph.D. is a featured moderator at the Tech Transfer Summit (“TTS”) North America 2013. Details for their programs are as follows:
July 29 – 3:30 p.m.
KOL Insight: The most important emerging trends & developments in global biotech IP and their significance for TTOs and early-stage biotech
Presenter:
Kevin Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP
July 29 – 3:45 p.m.
What crucial new developments in IP law and US legislation are of greatest concern to TTOs and early stage biotech and their investors?
Moderator:
Paul Tully, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP
Presenters:
Kevin Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP
Rita Hao, Senior Counsel, Office of the President, University of California
Karin Immergluck, Acting Director, ITA Technology Man
About TTS North America 2013
The premier meeting and benchmark for technology transfer events in the biotechnology sector, the TTS North America is the flagship event of the TTS Global Initiative and is organized together with a consortium of the leading technology transfer organizations from both the public and private sectors, and with the support of key industry and leading technology transfer, IP, licensing and other specialized organizations. Join international experts and executives from industry, finance and IP in sourcing the best technology and the pioneering tech transfer and early-stage biotech venture meeting.
Sponsored by: TTS Ltd.
View complete details including registration at http://www.techtransfersummit.com/northamerica2013/